Log in

NASDAQ:NVCN - Neovasc Stock Price, Forecast & News

$1.46
-0.14 (-8.75 %)
(As of 04/1/2020 04:47 AM ET)
Today's Range
$1.38
Now: $1.46
$1.61
50-Day Range
$1.49
MA: $2.36
$3.07
52-Week Range
$1.38
Now: $1.46
$8.65
Volume262,624 shs
Average Volume348,296 shs
Market Capitalization$16.25 million
P/E Ratio1.46
Dividend YieldN/A
Beta1.95
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets cardiovascular devices worldwide. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company also provides Peripatch tissue products. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.
Read More
Neovasc logo

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:NVCN
CUSIPN/A
Phone604-248-4138

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.75 million
Book Value($3.45) per share

Profitability

Net Income$-108,040,000.00
Net Margins-544.24%

Miscellaneous

Employees98
Market Cap$16.25 million
Next Earnings DateN/A
OptionableNot Optionable

Receive NVCN News and Ratings via Email

Sign-up to receive the latest news and ratings for NVCN and its competitors with MarketBeat's FREE daily newsletter.


Neovasc (NASDAQ:NVCN) Frequently Asked Questions

How has Neovasc's stock been impacted by COVID-19 (Coronavirus)?

Neovasc's stock was trading at $2.21 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, NVCN shares have decreased by 33.9% and is now trading at $1.46. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Neovasc?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Neovasc in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Neovasc.

How were Neovasc's earnings last quarter?

Neovasc Inc (NASDAQ:NVCN) issued its earnings results on Monday, March, 30th. The medical equipment provider reported ($1.45) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.63) by $0.82. View Neovasc's earnings history.

When did Neovasc's stock split? How did Neovasc's stock split work?

Neovasc's stock reverse split on Friday, September 21st 2018. The 1-100 reverse split was announced on Tuesday, September 11th 2018. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, September 20th 2018. An investor that had 100 shares of Neovasc stock prior to the reverse split would have 1 shares after the split.

What price target have analysts set for NVCN?

2 brokers have issued 12-month target prices for Neovasc's stock. Their forecasts range from $3.00 to $9.00. On average, they expect Neovasc's share price to reach $6.00 in the next year. This suggests a possible upside of 311.0% from the stock's current price. View analysts' price targets for Neovasc.

Has Neovasc been receiving favorable news coverage?

Headlines about NVCN stock have been trending very negative on Wednesday, according to InfoTrie. The research group identifies positive and negative news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Neovasc earned a media sentiment score of -3.0 on InfoTrie's scale. They also gave press coverage about the medical equipment provider a news buzz of 4.0 out of 10, meaning that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the next several days. View the latest news aboutNeovasc.

Are investors shorting Neovasc?

Neovasc saw a increase in short interest in the month of March. As of March 13th, there was short interest totaling 221,800 shares, an increase of 20.9% from the February 27th total of 183,500 shares. Based on an average daily trading volume, of 92,500 shares, the short-interest ratio is currently 2.4 days. Currently, 2.4% of the shares of the stock are sold short. View Neovasc's Current Options Chain.

Who are some of Neovasc's key competitors?

What other stocks do shareholders of Neovasc own?

Who are Neovasc's key executives?

Neovasc's management team includes the following people:
  • Mr. Fredericus A. Colen, Pres & CEO (Age 66)
  • Mr. Christopher Clark B.A., C.A., BA (Honours), PgD, CA, CFO & Corp. Sec. (Age 47)

What is Neovasc's stock symbol?

Neovasc trades on the NASDAQ under the ticker symbol "NVCN."

How do I buy shares of Neovasc?

Shares of NVCN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Neovasc's stock price today?

One share of NVCN stock can currently be purchased for approximately $1.46.

How big of a company is Neovasc?

Neovasc has a market capitalization of $16.25 million and generates $1.75 million in revenue each year. The medical equipment provider earns $-108,040,000.00 in net income (profit) each year or ($27.30) on an earnings per share basis. Neovasc employs 98 workers across the globe. View additional information about Neovasc.

What is Neovasc's official website?

The official website for Neovasc is http://www.neovasc.com/.

How can I contact Neovasc?

Neovasc's mailing address is Suite 5138 - 13562 Maycrest Way, Richmond A1, V6V2J7. The medical equipment provider can be reached via phone at 604-248-4138 or via email at [email protected]


MarketBeat Community Rating for Neovasc (NASDAQ NVCN)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  382 (Vote Outperform)
Underperform Votes:  301 (Vote Underperform)
Total Votes:  683
MarketBeat's community ratings are surveys of what our community members think about Neovasc and other stocks. Vote "Outperform" if you believe NVCN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NVCN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 4/1/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel